Why researchers only researched the
last five months of 2013 for this is somewhat of a puzzle unless they
also had an agenda. Internal medicine and orthopedic surgery
received the greatest total value at $111 million each. The highest
proportion of physicians receiving payments was seen among
cardiovascular and neurosurgical specialists.
Jona Hattangadi-Gluth, MD, principal
investigator and assistant professor at UC San Diego School of
Medicine stated, "Physicians across the nation have entered
into an era of transparency. This analysis shows the wide variability
of industry payments across specialties. The research sheds light on
how physicians are engaging with medical companies, and this
information can be used by patients, policymakers and other
stakeholders when making health care decisions."
“The study found that medical
specialties requiring a higher level of intervention, such as
gastroenterology, cardiology and orthopedics, received higher
payments - likely because of the dependence on devices used by the
physicians for procedures, such as stents or hip replacements.”
"During the last few decades,
physicians have become much more engaged in the development of novel
drugs and devices, which is critical to bringing innovation to
patients," said Hattangadi-Gluth, chief of the central nervous
system tumor service at UC San Diego Health. "Certain
specialties, like surgery, may require more research and involvement
in device development, resulting in higher royalty and license
payments. Our study not only identified how industry payments are
distributed by specialty, it also helped put those payments in
context."
When you use the search tool on the
open payments site, you will enter the first and last name of the
physician and you will be able to see industry payments to the
individual listed by company, nature of payment, date, and amount.
Using this information, the determination needs to be made if the
financial relationship creates a conflict of interest or are they
appropriate to ensure the highest quality of care and patient trust.
“Hattangadi-Gluth said next steps
include looking at whether an industry payment affects physician
decision-making and treatment utilization. We don't know yet whether
these financial relationships are harmful in any way. It is also
unclear whether transparency will impede valuable collaborations and
the pace of innovation. There are many positive consequences of
physician-industry relationships, so it is important that they be
interpreted properly."
This is probably the hardest decision
for the patient to determine. I have been very careful to ask one or
two questions of the doctor and base my decision on how the doctor
answers. For one doctor, I knew he had been the one that developed
the device and if figured that payment was a royalty, and when he
answered the explanation fit. For the second question, he was a
little more evasive, so I asked another question about having a
conflict of interest. Finally, he admitted that it was and he
received a payment for every time the company was reimbursed for the
device.